Priorix-Tetra 1000 Ccid50

Priorix-Tetra 1000 CCID50 is a live attenuated rubella virus vaccine designed for immunization. This powder for solution is administered intramuscularly to help prevent rubella and other vaccine-preventable diseases.

Priorix-Tetra 1000 CCID50 is used for the prevention of rubella, a viral infection that can cause serious complications. This vaccine is typically administered to individuals who are at risk of exposure to the rubella virus, including children and adults. The vaccine works by stimulating the body's immune system to produce antibodies against the rubella virus, providing protection against future infections.

Common effects of Priorix-Tetra 1000 CCID50 may include mild fever, soreness at the injection site, and general discomfort. These effects are usually temporary and resolve within a few days. Severe reactions are rare but can occur, and individuals should seek medical attention if they experience persistent or severe symptoms.

Priorix-Tetra 1000 CCID50 should be handled with care and stored according to the manufacturer's instructions. Individuals with a history of severe allergic reactions to previous doses of rubella vaccine or any of its components should avoid this vaccine. It is important to consult a healthcare provider before administration to ensure it is suitable for the individual's health condition.

Priorix-Tetra 1000 CCID50 may interact with certain medications, including immunosuppressants and other live vaccines. Alcohol and other substances that weaken the immune system may also affect the vaccine's effectiveness. It is advisable to discuss all current medications and health conditions with a healthcare provider before receiving this vaccine.